{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:02:14Z","timestamp":1774436534693,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003653","name":"Korea National Institute of Health","doi-asserted-by":"publisher","award":["4800-4842-304"],"award-info":[{"award-number":["4800-4842-304"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"Korea National Institute of Health","doi-asserted-by":"publisher","award":["2012-N51003-00"],"award-info":[{"award-number":["2012-N51003-00"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jcv.2016.06.001","type":"journal-article","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T00:27:27Z","timestamp":1464913647000},"page":"53-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The trend of transmitted drug resistance in newly diagnosed antiretroviral-naive HIV\/AIDS patients during 1999\u20132012 in South Korea"],"prefix":"10.1016","volume":"81","author":[{"given":"Mina","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mee-Kyung","family":"Kee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JeeEun","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Soon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-yeon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2016.06.001_bib0005","unstructured":"Antiretroviral drugs used in the treatment of HIV infection, U.S. Food and Drug Administration, August 10, 2015, Available at: http:\/\/www.fda.gov\/forpatients\/illness\/hivaids\/ucm118915.htm."},{"key":"10.1016\/j.jcv.2016.06.001_bib0010","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2165\/11633630-000000000-00000","article-title":"HIV-1 antiretroviral resistance scientific principles and clinical applications","volume":"72","author":"Tang","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.jcv.2016.06.001_bib0015","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(98)03201-2","article-title":"Changing patterns of mortality across Europe in patients infected with HIV-1","volume":"352","author":"Mocroft","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2016.06.001_bib0020","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2016.06.001_bib0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/QAI.0b013e318188a919","article-title":"National survey for drug-resistant variants in newly diagnosed antiretroviral drug-na\u00efve patients with HIV\/AIDS in South Korea: 1999\u20132005","volume":"49","author":"Choi","year":"2008","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jcv.2016.06.001_bib0030","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1089\/08892220152644250","article-title":"Phylogenetic analysis of reverse transcriptase in antiretroviral drug-na\u00efve Korean HIV-1 Type 1 patients","volume":"17","author":"Sung","year":"2001","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.jcv.2016.06.001_bib0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/aid.2007.0116","article-title":"Prevalence of primary antiretroviral resistance: trends in Korea","volume":"24","author":"Bang","year":"2008","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.jcv.2016.06.001_bib0040","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1089\/aid.2007.0008","article-title":"High frequency of drug resistance mutations in human immunodeficiency virus type 1-infected Korean patients treated with HAART","volume":"23","author":"Sung","year":"2007","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.jcv.2016.06.001_bib0045","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/088922203766774586","article-title":"Natural polymorphisms of protease inhibitor-na\u00efve HIV-1 infected patients in Korea: a novel L63M in subtype B","volume":"19","author":"Sung","year":"2003","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.jcv.2016.06.001_bib0050","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1089\/aid.2006.0255","article-title":"Early modification of initial HAART regimen associated with poor clinical outcome in HIV patients","volume":"23","author":"Park","year":"2007","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.jcv.2016.06.001_bib0055","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1365-2796.2006.01762.x","article-title":"One-year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients","volume":"261","author":"Park","year":"2007","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jcv.2016.06.001_bib0060","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1089\/aid.2013.0184","article-title":"HIV antiretroviral resistance mutations among antiretroviral treatment-na\u00efve and \u2212experienced patients in South Korea","volume":"29","author":"Kim","year":"2013","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.jcv.2016.06.001_bib0065","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/aid.2009.0157","article-title":"Comparison of genotypic resistance mutations in treatment-na\u00efve HIV type 1-infected patients in Korea and China","volume":"26","author":"Chin","year":"2010","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.jcv.2016.06.001_bib0070","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/QAD.0b013e3283388742","article-title":"Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses U.S.-2006","volume":"24","author":"Wheeler","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jcv.2016.06.001_bib0075","doi-asserted-by":"crossref","first-page":"e15510","DOI":"10.1371\/journal.pone.0015510","article-title":"Transmitted drug resistance in persons with acute\/early HIV-1 in San Francisco 2002\u20132009","volume":"5","author":"Jain","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2016.06.001_bib0080","doi-asserted-by":"crossref","first-page":"e25281","DOI":"10.1371\/journal.pone.0025281","article-title":"Sentinelsurveillance of HIV-1 transmitted drug resistance, acute infection and recent infection","volume":"6","author":"Truong","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2016.06.001_bib0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/SMJ.0b013e3181fcd75b","article-title":"Transmitted antiretroviral drug resistance in individuals with newly diagnosed HIV infection: South Carolina 2005\u20132009","volume":"104","author":"Youmans","year":"2011","journal-title":"South. Med. J."},{"key":"10.1016\/j.jcv.2016.06.001_bib0090","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/432916","article-title":"Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management","volume":"192","author":"Wensing","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2016.06.001_bib0095","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.antiviral.2010.07.008","article-title":"Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in Japan","volume":"88","author":"Hattori","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jcv.2016.06.001_bib0100","first-page":"17","article-title":"Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world","volume":"14","author":"Frentz","year":"2012","journal-title":"AIDS Rev."},{"key":"10.1016\/j.jcv.2016.06.001_bib0105","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1086\/644505","article-title":"Transmission of drug-resistant HIV-1 is stabilizing in Europe","volume":"200","author":"Vercauteren","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2016.06.001_bib0110","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/bmj.38665.534595.55","article-title":"Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study","volume":"331","author":"Cane","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jcv.2016.06.001_bib0115","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.meegid.2011.01.019","article-title":"Epidemiological network analysis in HIV-1B infected patients diagnosed in Italy between 2000 and 2008","volume":"11","author":"Callegaro","year":"2011","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.jcv.2016.06.001_bib0120","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.medcli.2009.09.029","article-title":"Epidemiology of drug-resistant HIV-1 transmission in na\u00efve patients in Spain (In Spanish)","volume":"135","author":"Yebra","year":"2010","journal-title":"Med. Clin. (Barc)."},{"key":"10.1016\/j.jcv.2016.06.001_bib0125","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1093\/jac\/dkt238","article-title":"National sentinel surveillance of transmitted drug resistance in antiretroviral-na\u00efve chronically HIV-infected patients in France over a decade: 2001\u20132011","volume":"68","author":"Descamps","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jcv.2016.06.001_bib0130","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/jac\/dkt003","article-title":"Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-na\u00efve patients infected with B and non-B subtype HIV-1 viruses","volume":"68","author":"Lambert-Niclot","year":"2013","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653216301330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653216301330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T08:26:42Z","timestamp":1536654402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653216301330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":26,"alternative-id":["S1386653216301330"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2016.06.001","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The trend of transmitted drug resistance in newly diagnosed antiretroviral-naive HIV\/AIDS patients during 1999\u20132012 in South Korea","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2016.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}